GLP Watchdog

Fridays vs GoodRx

Neither Fridays nor GoodRx has an FDA warning letter on record. On brand-name tirzepatide pen, GoodRx costs $18,348 less a year at standing rates: $299 a month against $1,828 a month at Fridays.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / GoodRx

Fridays logo

Fridays

5.8/10

GoodRx logo

GoodRx

7.8/10

FDA warning letters
None on record
None on record
Pharmacy
Brand-name only; no compounding
Lowest standing price
$249/moCompounded semaglutide injection
$149/moFoundayo (orforglipron) pill
States
No state list published
48 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Fridays
Visit GoodRx

Neither Fridays nor GoodRx pays us. Links to them earn nothing. Scores: Fridays 5.8, GoodRx 7.8. How we are paid

What the record shows

  1. 01

    Neither Fridays nor GoodRx has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. GoodRx sells brand-name medication only.

  3. 03

    On brand-name tirzepatide pen, GoodRx costs $18,348 less a year at standing rates: $299 a month against $1,828 a month at Fridays.

  4. 04

    Only Fridays lists a price for compounded semaglutide injection, compounded tirzepatide injection and brand-name semaglutide pen. Only GoodRx lists a price for Foundayo (orforglipron) pill.

  5. 05

    GoodRx lists 48 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

GoodRx

Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

$299/moLower

$3,588 a year

Compounded semaglutide injection

$249/mo

$2,988 a year

Not sold or not priced
Compounded tirzepatide injection

$359/mo

$4,308 a year

Not sold or not priced
Brand-name semaglutide pen

$1,498/mo

$17,976 a year

Not sold or not priced
Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

$1,788 a year

Price includes
Medication, clinician visits, coaching
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
None
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
Services and medication are generally non-refundable

Read off each seller’s own pages. Fridays: October 30, 2026. GoodRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which GoodRx does not price
  • Publishes no state list
Visit Fridays

The case for GoodRx

7.8/10
  • $18,348 a year less on brand-name tirzepatide pen
  • Sells Foundayo (orforglipron) pill, which Fridays does not price
Visit GoodRx

Scores

Fridays 5.8 · GoodRx 7.8 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
8.7

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
5.0

Trust & Safety15%

5.5A
vs
B
6.0

Accessibility10%

5.0A
vs
B
9.7

Support10%

7.0A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs GoodRx: questions

Neither Fridays nor GoodRx has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. GoodRx sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
GoodRx, by $18,348 a year at standing rates. Fridays: $1,828 a month, about $21,936 a year. GoodRx: $299 a month, about $3,588 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. GoodRx states you can cancel at any time; refunds: services and medication are generally non-refundable.
Neither Fridays nor GoodRx pays us. Links to them earn nothing. Scores: Fridays 5.8, GoodRx 7.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks